A phase II study of gemcitabine (G) and capecitabine (C) in patients with metastatic renal cell cancer (mRCC): A report of Cancer and Leukemia Group B #90008.
Publication
, Conference
Stadler, WM; Halabi, S; Ernstoff, MS; Barrier, R; Davila, E; Picus, J; Small, EJ
Published in: JOURNAL OF CLINICAL ONCOLOGY
July 15, 2004
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
ISSN
0732-183X
Publication Date
July 15, 2004
Volume
22
Issue
14
Start / End Page
385S / 385S
Location
New Orleans, LA
Publisher
AMER SOC CLINICAL ONCOLOGY
Conference Name
40th Annual Meeting of the American-Society-of-Clinical-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Stadler, W. M., Halabi, S., Ernstoff, M. S., Barrier, R., Davila, E., Picus, J., & Small, E. J. (2004). A phase II study of gemcitabine (G) and capecitabine (C) in patients with metastatic renal cell cancer (mRCC): A report of Cancer and Leukemia Group B #90008. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 22, pp. 385S-385S). New Orleans, LA: AMER SOC CLINICAL ONCOLOGY.
Stadler, W. M., S. Halabi, M. S. Ernstoff, R. Barrier, E. Davila, J. Picus, and E. J. Small. “A phase II study of gemcitabine (G) and capecitabine (C) in patients with metastatic renal cell cancer (mRCC): A report of Cancer and Leukemia Group B #90008.” In JOURNAL OF CLINICAL ONCOLOGY, 22:385S-385S. AMER SOC CLINICAL ONCOLOGY, 2004.
Stadler WM, Halabi S, Ernstoff MS, Barrier R, Davila E, Picus J, et al. A phase II study of gemcitabine (G) and capecitabine (C) in patients with metastatic renal cell cancer (mRCC): A report of Cancer and Leukemia Group B #90008. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2004. p. 385S-385S.
Stadler, W. M., et al. “A phase II study of gemcitabine (G) and capecitabine (C) in patients with metastatic renal cell cancer (mRCC): A report of Cancer and Leukemia Group B #90008.” JOURNAL OF CLINICAL ONCOLOGY, vol. 22, no. 14, AMER SOC CLINICAL ONCOLOGY, 2004, pp. 385S-385S.
Stadler WM, Halabi S, Ernstoff MS, Barrier R, Davila E, Picus J, Small EJ. A phase II study of gemcitabine (G) and capecitabine (C) in patients with metastatic renal cell cancer (mRCC): A report of Cancer and Leukemia Group B #90008. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2004. p. 385S-385S.
Published In
JOURNAL OF CLINICAL ONCOLOGY
ISSN
0732-183X
Publication Date
July 15, 2004
Volume
22
Issue
14
Start / End Page
385S / 385S
Location
New Orleans, LA
Publisher
AMER SOC CLINICAL ONCOLOGY
Conference Name
40th Annual Meeting of the American-Society-of-Clinical-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences